Abstract
Drug metabolizing enzyme induction, or the process of generating excess drug metabolizing enzyme in important tissues of drug disposition such as liver and intestine, can give rise to pharmacokinetic situations whereby drug interactions occur. There are two major concerns associated with enzyme induction. First is the potential loss of efficacy due to more rapid metabolism and second is the risk of an increase in the formation of a potential reactive/toxic metabolite. Because of this, pharmaceutical companies consider enzyme induction as an undesired drug property for their potential drug candidates. As a consequence, the number of tools and models to evaluate induction of drug metabolizing enzymes has been increased tremendously over the past decade. As often is the case, every assay and approach has its own advantages and disadvantages and unfortunately, no single tool is currently available to predict the induction potential of drug candidates in humans. The purpose of this review is not only to outline the screening tools currently available for determining the induction potential of new chemical entities but also to translate these tools into a valuable screening strategy, covering aspects such as, induction liability assessment, structure-activity relationships (SAR), induction risk assessment and translating in vitro findings into clinical relevance.
Keywords: Induction, cytochrome P450, screening, assays, mechanism, drug-drug interactions
Combinatorial Chemistry & High Throughput Screening
Title: Enzyme Induction: Translating Multiple Approaches, Assays, Endpoints, and Opinions into a Valuable Induction Screening Strategy
Volume: 13 Issue: 2
Author(s): Adrian Fretland and Mario Monshouwer
Affiliation:
Keywords: Induction, cytochrome P450, screening, assays, mechanism, drug-drug interactions
Abstract: Drug metabolizing enzyme induction, or the process of generating excess drug metabolizing enzyme in important tissues of drug disposition such as liver and intestine, can give rise to pharmacokinetic situations whereby drug interactions occur. There are two major concerns associated with enzyme induction. First is the potential loss of efficacy due to more rapid metabolism and second is the risk of an increase in the formation of a potential reactive/toxic metabolite. Because of this, pharmaceutical companies consider enzyme induction as an undesired drug property for their potential drug candidates. As a consequence, the number of tools and models to evaluate induction of drug metabolizing enzymes has been increased tremendously over the past decade. As often is the case, every assay and approach has its own advantages and disadvantages and unfortunately, no single tool is currently available to predict the induction potential of drug candidates in humans. The purpose of this review is not only to outline the screening tools currently available for determining the induction potential of new chemical entities but also to translate these tools into a valuable screening strategy, covering aspects such as, induction liability assessment, structure-activity relationships (SAR), induction risk assessment and translating in vitro findings into clinical relevance.
Export Options
About this article
Cite this article as:
Fretland Adrian and Monshouwer Mario, Enzyme Induction: Translating Multiple Approaches, Assays, Endpoints, and Opinions into a Valuable Induction Screening Strategy, Combinatorial Chemistry & High Throughput Screening 2010; 13 (2) . https://dx.doi.org/10.2174/138620710790596727
DOI https://dx.doi.org/10.2174/138620710790596727 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Eco-friendly Agents for Biological Control of Pathogenic Diseases
The discovery of an alternative biological approach to disease management includes work on medicinal products derived from natural sources as a starting point for the development of eco-friendly agents for these diseases and the injuries they cause, as well as reducing human contact with hazardous chemicals and their residues. We ...read more
Emerging trends in diseases mechanisms, noble drug targets and therapeutic strategies: focus on immunological and inflammatory disorders
Recently infectious and inflammatory diseases have been a key concern worldwide due to tremendous morbidity and mortality world Wide. Recent, nCOVID-9 pandemic is a good example for the emerging infectious disease outbreak. The world is facing many emerging and re-emerging diseases out breaks at present however, there is huge lack ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Scope of the Thematic Issue: Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute force experimentation, which can be time-consuming and resource-intensive. Spectral Graph Theory, a branch of mathematics dealing with the properties of graphs in relation to the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug Targets Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
Current Pharmaceutical Design The Involvement of Lysosomes in Myocardial Aging and Disease
Current Cardiology Reviews Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia
Current Cancer Drug Targets In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Current Medicinal Chemistry - Central Nervous System Agents NF-κB in Anti-Inflammatory Activity of Probiotics: An Update
Current Immunology Reviews (Discontinued) An Overview of Phytotherapeutic Approaches for the Treatment of Benign Prostatic Hyperplasia
Mini-Reviews in Medicinal Chemistry Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis
Current Drug Metabolism Recent Advances in the Membrane Receptor Initiated Vitamin D Signaling of Calcium and Phosphate Transport Across Intestinal and Kidney Epithelia
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Laminin and Collagen IV: Two Polypeptides as Marker of Dystocic Labor
Current Protein & Peptide Science Cancer Chemoprevention Drug Targets
Current Drug Targets Cytochromes P450 in Brain: Function and Significance
Current Drug Metabolism Editorial on the Occasion of the 20th Anniversary of Endocrine Metabolic Immune Disorders-Drug Targets Journal with a Kaleidoscopic Vision of Selected Publications
Endocrine, Metabolic & Immune Disorders - Drug Targets The Epidermis as a Model for Tissue Engineering
Current Tissue Engineering (Discontinued) Alternative Splicing Regulation and Cell Lineage Differentiation
Current Stem Cell Research & Therapy Alternative Splice Variants of Survivin as Potential Targets in Cancer
Current Drug Discovery Technologies Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review
Current Drug Targets Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours
Current Signal Transduction Therapy Targeting Calcium Channels to Block Tumor Vascularization
Recent Patents on Anti-Cancer Drug Discovery